JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gyermek, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gyermek, L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 127, Issue 4, 313-317, 1959
Copyright © 1959 by American Society for Pharmacology and Experimental Therapeutics


DIFFERENCES BETWEEN ATROPINE-LIKE AND GANGLIONIC BLOCKING AGENTS IN THEIR ACTION ON THE MOUSE PUPIL

Laszlo Gyermek 1

1 Department of Pharmacology, University of Illinois College of Medicine, Chicago, Illinois

The influence of carbaminoylcholine (Cch, 2 mg/kg, s.c.) on the mydriasis produced by cholinergic blocking agents was determined in mice. Pretreatment with Cch did not alter the mydriasis produced by atropine, scopolamine, and benactyzine (tertiary amines having postganglionic parasympathetic blocking property). On the other hand, the mydriatic effect of ganglionic blocking agents (hexamethonium, mecamylamine, and p-phenylbenzyl tropanium bromide) was inhibited by Cch. The pretreatment decreased to a variable but not significant extent the mydriatic effect of those quaternary ammonium compounds which have both atropinelike and ganglionic blocking properties.

The interaction found between Ceh and cholinergic blocking drugs (atropine-like and ganglionic blocking) on the mouse pupil appears to be useful in determining their site of cholinergic blockade. The method is not suitable for measuring the absolute quantity of the ganglionic blocking action of drugs which exhibit both ganglionic and postganglionic blockade, but may give an estimate of the predominance of one or the other action.

Submitted on June 5, 1959







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1959 by the American Society for Pharmacology and Experimental Therapeutics.